StockData
LeonaBio, Inc. logo

LeonaBio, Inc. (LONA) stock

LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.65−0.11 (-3.99%)

Close on Nov 18, 2026Market cap $24.97MP/E –Yield –

Earnings

LeonaBio's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 5, 2026
Q3 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
–
EPS, Q2 FY2026
-$0.80
$0.18 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of LeonaBio's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 5, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 14, 2026during market hours––-$0.80Release
Q1 FY2026ended Mar 31, 2026May 7, 2026during market hours–––Release
Q4 FY2025ended Dec 31, 2025Mar 26, 2026during market hours–––Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025during market hours––-$1.68Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025during market hours––$0.18Release
Q1 FY2025ended Mar 31, 2025May 9, 2025during market hours––-$0.23Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025during market hours–––Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024during market hours–––Release
Q2 FY2024ended Jun 30, 2024Aug 1, 2024during market hours––-$0.70Release
Q1 FY2024ended Mar 31, 2024May 15, 2024during market hours––-$0.69Release
Q4 FY2023ended Dec 31, 2023Feb 22, 2024during market hours–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

LeonaBio has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When LeonaBio puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases LeonaBio filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Update
  7. Update
  8. Update
  9. Update
  10. Update
  11. Update
  12. Update
  13. Results
  14. Results
  15. Results

See a number that looks wrong?